Not applicableStudy completedNCT04813679What this trial is testingBed-side Ultrasound in Neutropenic EnterocolitisWho this might be right forNeutropenic Enterocolitis Azienda Ospedaliero, Universitaria Pisana 1,740
Not applicableStudy completedNCT05671393What this trial is testingThe Optimal Surveillance Frequency for Patients With Gastric Neuroendocrine CarcinomaWho this might be right forGastric Neuroendocrine Carcinoma Fujian Medical University 801
Testing effectiveness (Phase 2)Study completedNCT00331201What this trial is testingSAFEstart Feeding Intolerance Study Phase IIWho this might be right forFeeding IntoleranceAbdominal DistentionGastric Residual+2 more Intermountain Health Care, Inc. 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 818
Testing effectiveness (Phase 2)Active Not RecruitingNCT02595424What this trial is testingCisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine CarcinomasWho this might be right forGastric Neuroendocrine CarcinomaIntestinal Neuroendocrine CarcinomaPancreatic Neuroendocrine Carcinoma ECOG-ACRIN Cancer Research Group 67
Testing effectiveness (Phase 2)Looking for participantsNCT06943521What this trial is testingMT-4561 in Patients With Various Advanced Solid TumorsWho this might be right forHead and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)Esophageal Cancer+13 more Tanabe Pharma America, Inc. 27
Testing effectiveness (Phase 2)Looking for participantsNCT06503146What this trial is testing18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer DetectionWho this might be right forSarcomaSmall Cell Lung Cancer or Extrapulmonary Neuroendocrine Cancer (EP-NEC)Mesothelioma+7 more National Cancer Institute (NCI) 320
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07337447What this trial is testingTrial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI With a Hybrid Synthetic Control Arm in Second Line Treatment of Neuroendocrine Carcinoma of Gastro-enteropancreatic or Unknown Origin (REWENEC 01)Who this might be right forCarcinoma, Neuroendocrine Hospices Civils de Lyon 122
Not applicableStudy completedNCT03111329What this trial is testingDoes Routine Assessment of Gastric Residuals in Preterm Neonates Influence Time Taken to Reach Full Enteral Feeding?Who this might be right forGastric Residuals AssessmentPrematuritySepsis Newborn+1 more Institute for the Care of Mother and Child, Prague, Czech Republic 95
Not applicableEnrolling By InvitationNCT03123835What this trial is testingOutcome Analysis of POEM and Endoluminal TherapiesWho this might be right forAchalasiaGastric FistulaWeight Gain After Primary Weight Loss Surgery+3 more University of California, Davis 500
Not applicableStudy completedNCT06663852What this trial is testingML Decision Model for G-NEC Adjuvant TherapyWho this might be right forGastric Neuroendocrine Carcinoma (G-NEC)Postoperative Adjuvant Therapy for G-NECSurvival Outcomes+1 more Chang-Ming Huang, Prof. 1,505
Not applicableUnknownNCT05734118What this trial is testingSafety and Feasibility of Indocyanine Green Fluorescence for Intraoperative Assessment of Intestinal Perfusion in Young Infants and NeonatesWho this might be right forNECAtresiaMalrotation+1 more University Medical Center Groningen 20
Testing effectiveness (Phase 2)UnknownNCT02409849What this trial is testingOctreotide LAR as Maintenance Treatment for Patients With NECWho this might be right forGastro-entero-pancreatic CarcinomaEsophageal Neuroendocrine Carcinoma Peking University 92
Not applicableUnknownNCT06102746What this trial is testingClinical Study of Surufatinib Plus Sintilimab Combined With Chemotherapy in the Treatment of Advanced Gastric Neuroendocrine CarcinomaWho this might be right forGastric Neuroendocrine Carcinoma Tianjin Medical University Cancer Institute and Hospital 20